What is the role of thiamine in refractory septic shock management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thiamine in Refractory Septic Shock

Current evidence does not support the use of thiamine supplementation in the management of refractory septic shock, as it has not been shown to improve mortality outcomes. 1

Current Guidelines on Thiamine in Septic Shock

  • The 2020 Surviving Sepsis Campaign international guidelines specifically recommend against the use of thiamine to treat children with sepsis-associated organ dysfunction (weak recommendation, low quality of evidence) 1
  • Thiamine is not mentioned as a recommended therapy in any of the major adult sepsis management guidelines, including the 2016 Surviving Sepsis Campaign guidelines 1
  • Current sepsis management guidelines focus on other interventions for refractory septic shock, including:
    • Fluid resuscitation 1
    • Vasopressor therapy with norepinephrine as first-line agent 1
    • Consideration of vasopressin (0.01-0.03 units/minute) as an adjunct to norepinephrine 2
    • Hydrocortisone for fluid-refractory, catecholamine-resistant shock 1
    • Evaluation for and correction of reversible causes (pneumothorax, pericardial tamponade, endocrine emergencies) 1

Evidence on Thiamine in Septic Shock

  • While thiamine deficiency is known to occur in critically ill patients and can be associated with lactic acidosis, the evidence for supplementation in septic shock is limited 3, 4
  • A 2018 retrospective cohort study showed that thiamine administration within 24 hours of admission in patients with septic shock was associated with improved lactate clearance and reduced 28-day mortality compared to matched controls 5
  • However, a 2020 retrospective study found no difference in delirium-free days or mortality when vitamin C and thiamine were administered to patients with septic shock 6
  • A 2023 review concluded that current evidence does not support pharmaconutrition with high-dose thiamine as either single therapy or combination therapy for improving clinical outcomes in critically ill septic patients 3

Management Algorithm for Refractory Septic Shock

  1. Initial Management:

    • Ensure adequate fluid resuscitation 1
    • Start norepinephrine as first-line vasopressor 1
    • Obtain appropriate cultures and administer broad-spectrum antibiotics 1
  2. For Persistent Hypotension Despite Norepinephrine:

    • Add vasopressin (0.01-0.03 units/minute) to norepinephrine 2
    • Consider epinephrine as an additional agent 1
    • Administer hydrocortisone 200-300 mg/day for adults with catecholamine-resistant shock 1
  3. Further Management of Refractory Shock:

    • Evaluate for and reverse pneumothorax, pericardial tamponade, or endocrine emergencies 1
    • Consider dobutamine for patients with evidence of persistent hypoperfusion despite adequate fluid loading and vasopressor use 1
    • In pediatric patients, consider ECMO for refractory septic shock 1

Common Pitfalls and Caveats

  • Despite some promising retrospective data on thiamine for lactate clearance, there is insufficient evidence to recommend its routine use in septic shock 3, 4
  • Focusing on unproven adjunctive therapies like thiamine may delay implementation of evidence-based interventions that are known to improve outcomes 1
  • Thiamine deficiency should be considered and treated in specific at-risk populations (alcoholics, malnourished patients) but not as a routine intervention for all septic shock patients 7
  • The concept of multi-micronutrient administration (thiamine with vitamin C and corticosteroids) has shown mixed results and requires further investigation before clinical implementation 7

In conclusion, while thiamine deficiency may contribute to lactic acidosis in some septic patients, current guidelines and evidence do not support routine thiamine supplementation as a standard treatment for refractory septic shock. Management should focus on established interventions including appropriate fluid resuscitation, vasopressor therapy, source control, and addressing reversible causes of shock.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vasopressin Dosage and Titration in Sepsis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Thiamine (vitamin B1) in septic shock: a targeted therapy.

Journal of thoracic disease, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.